MARKET

IDXX

IDXX

Idexx Labs Inc
NASDAQ
346.02
-4.10
-1.17%
After Hours: 342.94 -3.08 -0.89% 16:03 10/06 EDT
OPEN
349.20
PREV CLOSE
350.12
HIGH
353.95
LOW
345.00
VOLUME
274.27K
TURNOVER
0
52 WEEK HIGH
672.93
52 WEEK LOW
318.50
MARKET CAP
28.81B
P/E (TTM)
44.72
1D
5D
1M
3M
1Y
5Y
Baron Funds Believes IDEXX Laboratories (IDXX) has the Strongest Competitive Position Ever
Baron Funds, an asset management company, released its “Baron Asset Fund” investor letter. You can download a copy of the same here. In the second quarter, the fund fell 21.09%. However, the firm believes that the fund is positioned to perform well in the ...
Insider Monkey · 08/30 18:51
OCPNY vs. IDXX: Which Stock Should Value Investors Buy Now?
OCPNY vs. IDXX: Which Stock Is the Better Value Option?
Zacks · 08/18 15:40
IDEXX (IDXX) Suffers From Macro Headwinds, Cost Constraints
The strengthening of the rate of exchange for the U.S. dollar relative to other currencies has a negative impact on IDEXX's (IDXX) revenues.
Zacks · 08/18 14:10
What Kind Of Shareholders Hold The Majority In IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Shares?
Every investor in IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) should be aware of the most powerful shareholder groups...
Simply Wall St. · 08/09 12:21
--Piper Sandler Adjusts Price Target on IDEXX Laboratories to $500 From $420, Reiterates Overweight Rating
--Piper Sandler Adjusts Price Target on IDEXX Laboratories to $500 From $420, Reiterates Overweight Rating
MT Newswires · 08/08 07:10
--Barclays Adjusts Price Target on IDEXX Laboratories to $582 From $700, Reiterates Overweight Rating
--Barclays Adjusts Price Target on IDEXX Laboratories to $582 From $700, Reiterates Overweight Rating
MT Newswires · 08/05 08:17
--Morgan Stanley Lowers IDEXX Laboratories Price Target to $573 From $603, Maintains Overweight Rating
--Morgan Stanley Lowers IDEXX Laboratories Price Target to $573 From $603, Maintains Overweight Rating
MT Newswires · 08/04 11:01
Research Alert: CFRA Keeps Hold Opinion On Shares Of Idexx Laboratories Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Idexx Laboratories Inc.
MT Newswires · 08/03 09:57
More
About IDXX
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. It also offers human medical point-of-care & laboratory diagnostics. Its products include health monitoring, others. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry.

Webull offers kinds of IDEXX Laboratories, Inc. stock information, including NASDAQ:IDXX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IDXX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IDXX stock methods without spending real money on the virtual paper trading platform.